The store will not work correctly when cookies are disabled.
N-(4-hydroxyphenyl)benzamide
ID: ALA229937
Cas Number: 15457-50-8
PubChem CID: 459327
Max Phase: Preclinical
Molecular Formula: C13H11NO2
Molecular Weight: 213.24
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Synonyms: N-(4-Hydroxyphenyl)Benzamide | N-(4-hydroxyphenyl)benzamide|15457-50-8|p-Benzamidophenol|Benzamide, N-(4-hydroxyphenyl)-|N-(4-Hydroxy-phenyl)-benzamide|4'-Hydroxybenzanilide|p-(N-Benzoylamino)phenol|N-(4-hydroxyphenyl)-benzamide|p-benzoylaminophenol|4-benzoylamino-phenol|N-benzoyl 4-hydroxyaniline|Oprea1_026787|Oprea1_270140|SCHEMBL679222|CHEMBL229937|DTXSID80165666|CVPWYDXAVJCNAG-UHFFFAOYSA-N|1-N-(4-Hydroxy-phenyl)-benzamide|MFCD00454145|AKOS000266826|AS-17960|CS-0307853|FT-0742194|EN300-08969|Show More⌵
Canonical SMILES: O=C(Nc1ccc(O)cc1)c1ccccc1
Standard InChI: InChI=1S/C13H11NO2/c15-12-8-6-11(7-9-12)14-13(16)10-4-2-1-3-5-10/h1-9,15H,(H,14,16)
Standard InChI Key: CVPWYDXAVJCNAG-UHFFFAOYSA-N
Molfile:
RDKit 2D
16 17 0 0 0 0 0 0 0 0999 V2000
-4.8092 -2.8002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.8104 -3.6277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0975 -4.0405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3782 -3.6272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.3814 -2.7962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0995 -2.3874 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6689 -2.3801 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9526 -2.7891 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2402 -2.3731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5278 -2.7848 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1840 -2.3694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1804 -1.5436 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5412 -1.1349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2501 -1.5525 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6731 -1.5553 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.8921 -1.1266 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7 8 1 0
8 9 1 0
4 5 1 0
9 10 2 0
2 3 1 0
10 11 1 0
5 6 2 0
11 12 2 0
6 1 1 0
12 13 1 0
1 2 2 0
13 14 2 0
14 9 1 0
5 7 1 0
7 15 2 0
3 4 2 0
12 16 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 213.24 | Molecular Weight (Monoisotopic): 213.0790 | AlogP: 2.64 | #Rotatable Bonds: 2 |
Polar Surface Area: 49.33 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.44 | CX Basic pKa: ┄ | CX LogP: 2.76 | CX LogD: 2.76 |
Aromatic Rings: 2 | Heavy Atoms: 16 | QED Weighted: 0.75 | Np Likeness Score: -0.86 |
References
1. Kumar A, Narasimhan B, Kumar D.. (2007) Synthesis, antimicrobial, and QSAR studies of substituted benzamides., 15 (12): [PMID:17428669] [10.1016/j.bmc.2007.03.074] |
2. Hansen HC, Chiacchia FS, Patel R, Wong NC, Khlebnikov V, Jankowska R, Patel K, Reddy MM.. (2010) Stilbene analogs as inducers of apolipoprotein-I transcription., 45 (5): [PMID:20106565] [10.1016/j.ejmech.2009.12.076] |